US Broker Ratings

Apellis Pharmaceuticals, Inc. (APLS)

⚠️ No article content returned.

..

SS Innovations International In (SSII)

⚠️ No article content returned.

..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Biotech Powerhouse with 33% Revenue Growth and Robust Buy Ratings

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a cutting-edge player in the biotechnology sector, has captured the attention of investors with its promising pipeline of peptide therapeutics targeting..

Evotec SE (EVO) Stock Analysis: Exploring 37% Potential Upside Amidst Volatile Sector Dynamics

In the competitive landscape of the healthcare sector, Evotec SE (EVO) stands out as a dynamic player in the drug discovery and development arena. Headquartered in..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A 145% Potential Upside Sparks Investor Interest

Dyne Therapeutics, Inc. (NASDAQ: DYN), a promising player in the biotechnology sector, has been capturing the attention of investors with a compelling potential upside of 145.46%...

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring a 20.83% Potential Upside in Healthcare Innovation

Guardian Pharmacy Services, Inc (GRDN) is a notable player in the healthcare sector, specifically within the medical care facilities industry. With its headquarters in Atlanta, Georgia,..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: A Biotech with Nearly 100% Upside Potential

Celldex Therapeutics, Inc. (NASDAQ: CLDX) is making waves in the biotechnology sector with its promising portfolio of therapeutic antibodies targeting severe inflammatory, allergic, and autoimmune diseases...

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A 145% Upside Potential Amidst Biotech Innovations

Investors with a keen eye on the biotechnology sector will find Edgewise Therapeutics, Inc. (NASDAQ: EWTX) a compelling prospect. With its focus on pioneering treatments for..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A 198.93% Potential Upside in Biotech Breakthroughs

Janux Therapeutics, Inc. (NASDAQ: JANX), a clinical-stage biopharmaceutical innovator, is making waves in the biotechnology sector with its pioneering immunotherapy solutions. Headquartered in San Diego, California,..

Organon & Co. (OGN) Stock Analysis: Exploring a 37% Potential Upside in Healthcare Investments

In the ever-evolving landscape of healthcare investments, Organon & Co. (NYSE: OGN) presents a compelling opportunity for investors seeking exposure to the drug manufacturing sector. With..

NovoCure Limited (NVCR): Investor Outlook on a Potential 103% Upside in the Medical Device Sector

NovoCure Limited (NASDAQ: NVCR), a Switzerland-based leader in the medical device industry, offers intriguing potential for investors looking to capitalize on its advancements in oncology. Specializing..

Concentra Group Holdings (CON) Stock Analysis: Unlocking a 39.44% Potential Upside in Healthcare

Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a leading provider of occupational health services in the United States, is catching the eye of investors with its..

Structure Therapeutics Inc. (GPCR): Investor Outlook with a 142% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR), a trailblazer in the biotechnology sector, has been capturing investor attention with its innovative approach to addressing chronic diseases. The company’s..

ImmunityBio, Inc. (IBRX): Investor Outlook with a 311% Potential Upside

For investors with an eye on the biotechnology sector, ImmunityBio, Inc. (NASDAQ: IBRX) presents a compelling narrative. With a market capitalization of $2.34 billion, the San..

Agios Pharmaceuticals (AGIO) Stock Analysis: Unveiling a 14% Upside Potential Amidst Robust Revenue Growth

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology sector with its focus on groundbreaking treatments in the field of cellular metabolism. Based in..

BGM Group Ltd. (BGM) Performance Highlights: A Closer Look at the Challenges and Opportunities in Healthcare Manufacturing

BGM Group Ltd. (BGM), a key player in China’s healthcare sector, operates within the drug manufacturing industry, focusing on both specialty and generic pharmaceuticals. With a..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A 75% Potential Upside Beckons Investors

IDEAYA Biosciences, Inc. (IDYA), a dynamic player in the biotechnology sector, is drawing significant investor attention with a notable potential upside of 75.79%. The company, headquartered..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Challenges with Strategic Potential in Healthcare

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the medical care facilities industry, continues to be a pivotal entity within the U.S. healthcare sector...

Alvotech (ALVO) Stock Analysis: Exploring a 119.57% Upside Potential in the Biosimilar Market

Alvotech (NASDAQ: ALVO), a Luxembourg-based company specializing in the development and manufacture of biosimilar medicines, has positioned itself as a compelling investment opportunity within the healthcare..

Alphatec Holdings, Inc. (ATEC) Investor Outlook: Uncovering a 44.64% Potential Upside

Alphatec Holdings, Inc. (NASDAQ: ATEC), a prominent player in the healthcare sector, is capturing investor attention with its innovative approach in the medical devices industry, particularly..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds